Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Physics in Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1088/0031-9155/45/1/309PMID 10661587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism.

  1999cited by this paper
• Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.

  1998cited by this paper
• Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography

  1997cited by this paper
• Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome.

  1996cited by this paper
• MIRDOSE: personal computer software for internal dose assessment in nuclear medicine.

  1996cited by this paper
• Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study

  1996cited by this paper
• Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity * . Results from a prospective, randomized, multicentre study

  1995cited by this paper
• Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease

  1995cited by this paper
• MIRD formulation.

  1993cited by this paper
• New simple method for thyroid volume determination by ultrasonography

  1992cited by this paper
• Iodine‐131 treatment of hyperthyroidism: current issues

  1991cited by this paper
• Dosage determination with radioactive isotopes; practical considerations in therapy and protection.

  1948cited by this paper

• 131I dose coefficients for a reference population using age-specific models

  2023influential citation
• Dose optimization in nuclear medicine therapy of benign and malignant thyroid diseases

  2016cites this paper
• Special Dosimetry Models

  2016cites this paper
• Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre

  2014cites this paper
• Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation

  2014cites this paper
• Basic principles in the radiation dosimetry of nuclear medicine.

  2014cites this paper
• Semi-automated 3D CT thyroid volumetry: Prospective comparative study of the thyroid volumes measured by specimen, 2D CT and US

  2014cites this paper
• The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

  2014cites this paper
• Semiautomated thyroid volumetry using 3D CT: prospective comparison with measurements obtained using 2D ultrasound, 2D CT, and water displacement method of specimen.

  2014cites this paper
• EANM Dosimetry Committee Series on Standard Operational Procedures for Pre-Therapeutic Dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases

  2013cites this paper
• Calculation of beta absorbed fractions for iodine isotopes in ellipsoidal thyroid lobe

  2013cites this paper
• Comparison of Absorbed Fraction of Gamma and Beta Rays of I-124 and I-131radio-Isotopes in Thyroid Gland with Monte Carlo Simulation

  2013cites this paper
• Nuclear Medicine Dose Assessment

  2012cites this paper
• دوز جذبی بتا و گامای ید 131 در تیروئید بیضیگون و سایر اندامهای گردن با استفاده از کد MCNPX

  2012cites this paper
• Absorbed dose estimations of 131I for critical organs using the GEANT4 Monte Carlo simulation code

  2012cites this paper
• Comparative study of MIRD, experimental and GEANT4 simulations for uniformly distributed I-131 in cylindrical and spherical thyroid models

  2012cites this paper
• The Use of Dosimetry in the Planning of Patient Therapy

  2012cites this paper
• Accuracy and reliability of thyroid volumetry using spiral CT and thyroid volume in a healthy, non-iodine-deficient Chinese adult population.

  2011cites this paper
• Thyroid volume’s influence on energy deposition from 131I calculated by Monte Carlo (MC) simulation

  2011cites this paper
• Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: Comparison between different methods

  2010cites this paper
• Therapy of large multinodular goitre using repeated doses of radioiodine

  2009cites this paper
• A System Dynamics Approach for the Development of a Patient-Specific Protocol for Radioiodine Treatment of Graves' Disease

  2009influential citation
• Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter

  2009cites this paper
• Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.

  2008cites this paper
• Models and Resources for Internal Dose Calculations

  2008cites this paper
• [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].

  2007cites this paper
• Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose

  2007cites this paper
• Optimized radioiodine therapy for Graves' disease: Two MIRD-based models for the computation of patient-specific therapeutic 131I activity

  2006cites this paper
• Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.

  2005cites this paper
• Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism.

  2004cites this paper
• The effects of recombinant human thyrotropin, in normal subjects and patients with goitre

  2004cites this paper
• Management of simple nodular goiter: current status and future perspectives.

  2003cites this paper
• Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.

  2002cites this paper
• A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease

  2002cites this paper
• The Use of Three-Dimensional Ultrasound for Thyroid Volumetry

  2001cites this paper
• Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves' disease.

  2001cites this paper